“…P. aeruginosa infection is associated with significant morbidity and mortality, prevalent with immuno-compromised patients and those with severe burns, diabetes, cancer, organ transplant, cystic fibrosis, chronic obstructive pulmonary disease, and on mechanical ventilation support [ 1 , 2 , 3 , 4 , 5 , 6 , 7 ]. P. aeruginosa infection of the lung alters the host genome to facilitate its replication and virulence and also initiates cascade of events in the host, including innate immune responses, reactive oxygen species (ROS) generation, cytokine production, inflammation, dysregulated lipid metabolism, and modulation of epigenetic factors [ 8 , 9 , 10 , 11 ]. Recent studies strongly suggest the regulation of sphingolipid metabolism and signaling pathways by P. aeruginosa infection of the mouse lung.…”